Skip to main content
Top
Published in: Surgical Endoscopy 5/2020

01-05-2020 | Splenectomy | 2019 SAGES Oral

Predicting venous thrombosis in patients undergoing elective splenectomy

Authors: Peter Szasz, Ali Ardestani, Brent T. Shoji, David C. Brooks, Ali Tavakkoli

Published in: Surgical Endoscopy | Issue 5/2020

Login to get access

Abstract

Background

Venous thrombosis (VT) is an ongoing problem for patients undergoing elective splenectomy. There is limited data evaluating risk factors for VTs. An increase in platelet counts is commonly seen after splenectomy; however, there is a paucity of literature evaluating post-operative platelet counts as a risk factor for VTs in this patient cohort. The objective of this study was to determine the incidence of VT events and to use the platelet count as a predictor for VT development.

Methods

A retrospective review was undertaken at Brigham Women’s Hospital, evaluating elective splenectomy patients between 1997 and 2018. Descriptive statistics were utilized to determine the incidence of VTs. Receiver operator characteristic (ROC) curves were utilized to identify platelet counts that could predict VTs.

Results

Five hundred and twenty splenectomies were included in the study of which 344 were completed in an open manner and 176 were done laparoscopically. The overall incidence of VT events was 6.7% (35/520), 6.1% (21/344) for open, and 8.0% (14/176) for laparoscopic approaches (p = 0.43). ROC curves demonstrated platelet counts to be a good predictor for the development of VTs with an area under the curve (AUC) of 0.77 (95% CI 0.69–0.86; p < 0.001) for all splenectomy patients, 0.70 (95% CI 0.59–0.81; p < 0.001) for those completed in an open manner, and 0.88 (95% CI 0.77–0.99; p < 0.001) for those done laparoscopically. The optimal platelet cutoff was found to be 545 for the overall splenectomy cohort, 457 for the open, and 659 for the laparoscopic cohorts. These platelet counts had a diagnostic accuracy that ranged from 61 to 86% and a negative predictive value (NPV) that ranged from 97 to 99%.

Conclusion

These results suggest platelet cutoffs that predict VTs. This information can be used to individualize prophylactic strategies.
Literature
1.
go back to reference Maurus CF, Schafer M, Muller MK, Clavien PA, Weber M (2008) Laparoscopic versus open splenectomy for nontraumatic diseases. World J Surg 32:2444–2449CrossRef Maurus CF, Schafer M, Muller MK, Clavien PA, Weber M (2008) Laparoscopic versus open splenectomy for nontraumatic diseases. World J Surg 32:2444–2449CrossRef
2.
go back to reference Shin RD, Lis R, Levergood NR, Brooks DC, Shoji BT, Tavakkoli A (2019) Laparoscopic versus open splenectomy for splenomegaly: the verdict is unclear. Surg Endosc 33:1298–1303CrossRef Shin RD, Lis R, Levergood NR, Brooks DC, Shoji BT, Tavakkoli A (2019) Laparoscopic versus open splenectomy for splenomegaly: the verdict is unclear. Surg Endosc 33:1298–1303CrossRef
3.
go back to reference Musallam KM, Khalife M, Sfeir PM, Faraj W, Safadi B, Abi Saad GS, Abiad F, Hallal A, Alwan MB, Peyvandi F, Jamali FR (2013) Postoperative outcomes after laparoscopic splenectomy compared with open splenectomy. Ann Surg 257:1116–1123CrossRef Musallam KM, Khalife M, Sfeir PM, Faraj W, Safadi B, Abi Saad GS, Abiad F, Hallal A, Alwan MB, Peyvandi F, Jamali FR (2013) Postoperative outcomes after laparoscopic splenectomy compared with open splenectomy. Ann Surg 257:1116–1123CrossRef
4.
go back to reference Bagrodia N, Button AM, Spanheimer PM, Belding-Schmitt ME, Rosenstein LJ, Mezhir JJ (2014) Morbidity and mortality following elective splenectomy for benign and malignant hematologic conditions: analysis of the American College of Surgeons National Surgical Quality Improvement Program data. JAMA Surg 149:1022–1029CrossRef Bagrodia N, Button AM, Spanheimer PM, Belding-Schmitt ME, Rosenstein LJ, Mezhir JJ (2014) Morbidity and mortality following elective splenectomy for benign and malignant hematologic conditions: analysis of the American College of Surgeons National Surgical Quality Improvement Program data. JAMA Surg 149:1022–1029CrossRef
5.
go back to reference Cadili A, de Gara C (2008) Complications of splenectomy. Am J Med 121:371–375CrossRef Cadili A, de Gara C (2008) Complications of splenectomy. Am J Med 121:371–375CrossRef
6.
go back to reference Krauth MT, Lechner K, Neugebauer EA, Pabinger I (2008) The postoperative splenic/portal vein thrombosis after splenectomy and its prevention—an unresolved issue. Haematologica 93:1227–1232CrossRef Krauth MT, Lechner K, Neugebauer EA, Pabinger I (2008) The postoperative splenic/portal vein thrombosis after splenectomy and its prevention—an unresolved issue. Haematologica 93:1227–1232CrossRef
7.
go back to reference Kimmig LM, Palevsky HI (2016) Review of the association between splenectomy and chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc 13:945–954CrossRef Kimmig LM, Palevsky HI (2016) Review of the association between splenectomy and chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc 13:945–954CrossRef
8.
go back to reference Montoro-Garcia S, Schindewolf M, Stanford S, Larsen OH, Thiele T (2016) The role of platelets in venous thromboembolism. Semin Thromb Hemost 42:242–251CrossRef Montoro-Garcia S, Schindewolf M, Stanford S, Larsen OH, Thiele T (2016) The role of platelets in venous thromboembolism. Semin Thromb Hemost 42:242–251CrossRef
9.
go back to reference Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, Fujiwara Y, Ohue M, Yasuda T, Imamura H, Tatsuta M, Yano M, Furukawa H, Monden M (2005) High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg 241:208–216CrossRef Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, Fujiwara Y, Ohue M, Yasuda T, Imamura H, Tatsuta M, Yano M, Furukawa H, Monden M (2005) High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg 241:208–216CrossRef
10.
go back to reference Habibzadeh F, Habibzadeh P, Yadollahie M (2016) On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Medica 26:297–307CrossRef Habibzadeh F, Habibzadeh P, Yadollahie M (2016) On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Medica 26:297–307CrossRef
11.
go back to reference Unal I (2017) Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med 2017:3762651CrossRef Unal I (2017) Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med 2017:3762651CrossRef
12.
go back to reference Koshenkov VP, Nemeth ZH, Carter MS (2012) Laparoscopic splenectomy: outcome and efficacy for massive and supramassive spleens. Am J Surg 203:517–522CrossRef Koshenkov VP, Nemeth ZH, Carter MS (2012) Laparoscopic splenectomy: outcome and efficacy for massive and supramassive spleens. Am J Surg 203:517–522CrossRef
13.
go back to reference Fraser SA, Bergman S, Garzon J (2012) Laparoscopic splenectomy: learning curve comparison between benign and malignant disease. Surg Innov 19:27–32CrossRef Fraser SA, Bergman S, Garzon J (2012) Laparoscopic splenectomy: learning curve comparison between benign and malignant disease. Surg Innov 19:27–32CrossRef
14.
go back to reference Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, Krespis E, Katsaragakis S, Bramis J (2006) Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 141:663–669CrossRef Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, Krespis E, Katsaragakis S, Bramis J (2006) Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 141:663–669CrossRef
15.
go back to reference Harris W, Marcaccio M (2005) Incidence of portal vein thrombosis after laparoscopic splenectomy. Can J Surg 48:352–354PubMedPubMedCentral Harris W, Marcaccio M (2005) Incidence of portal vein thrombosis after laparoscopic splenectomy. Can J Surg 48:352–354PubMedPubMedCentral
16.
go back to reference Khan PN, Nair RJ, Olivares J, Tingle LE, Li Z (2009) Postsplenectomy reactive thrombocytosis. Proceedings 22:9–12 Khan PN, Nair RJ, Olivares J, Tingle LE, Li Z (2009) Postsplenectomy reactive thrombocytosis. Proceedings 22:9–12
17.
go back to reference Buss DH, Cashell AW, O’Connor ML, Richards F 2nd, Case LD (1994) Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med 96:247–253CrossRef Buss DH, Cashell AW, O’Connor ML, Richards F 2nd, Case LD (1994) Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med 96:247–253CrossRef
18.
go back to reference Undas A, Brummel-Ziedins K, Mann KG (2014) Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid. J Thromb Haemost 12:1776–1787CrossRef Undas A, Brummel-Ziedins K, Mann KG (2014) Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid. J Thromb Haemost 12:1776–1787CrossRef
19.
go back to reference Koupenova M, Kehrel BE, Corkrey HA, Freedman JE (2017) Thrombosis and platelets: an update. Eur Heart J 38:785–791PubMed Koupenova M, Kehrel BE, Corkrey HA, Freedman JE (2017) Thrombosis and platelets: an update. Eur Heart J 38:785–791PubMed
20.
go back to reference Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902–4907CrossRef Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902–4907CrossRef
21.
go back to reference Jensvoll H, Blix K, Braekkan SK, Hansen JB (2014) Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromso Study. PloS ONE 9:e92011CrossRef Jensvoll H, Blix K, Braekkan SK, Hansen JB (2014) Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromso Study. PloS ONE 9:e92011CrossRef
22.
go back to reference Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (2000). Lancet 355:1295–1302 Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (2000). Lancet 355:1295–1302
23.
go back to reference Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J, Investigators A (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367:1979–1987CrossRef Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J, Investigators A (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367:1979–1987CrossRef
24.
go back to reference Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P, Investigators W (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366:1959–1967CrossRef Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P, Investigators W (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366:1959–1967CrossRef
25.
go back to reference Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e227S–e277SCrossRef Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e227S–e277SCrossRef
Metadata
Title
Predicting venous thrombosis in patients undergoing elective splenectomy
Authors
Peter Szasz
Ali Ardestani
Brent T. Shoji
David C. Brooks
Ali Tavakkoli
Publication date
01-05-2020
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 5/2020
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-07007-2

Other articles of this Issue 5/2020

Surgical Endoscopy 5/2020 Go to the issue